Speca, Silvia http://orcid.org/0000-0001-8494-3329
Farhat, Meryem-Maud http://orcid.org/0000-0002-9098-4984
Jendoubi, Manel http://orcid.org/0000-0002-1047-1274
Guerrier, Thomas http://orcid.org/0000-0001-8232-9405
Sanges, SĂ©bastien http://orcid.org/0000-0003-0280-411X
Staumont-Sallé, Delphine http://orcid.org/0000-0002-4780-4212
Hachulla, Eric http://orcid.org/0000-0001-7432-847X
Dubucquoi, Sylvain http://orcid.org/0000-0002-8962-3719
Sobanski, Vincent http://orcid.org/0000-0003-3083-2441
Collet, Aurore http://orcid.org/0000-0002-8279-1912
Launay, David http://orcid.org/0000-0003-1840-1817
Funding for this research was provided by:
Octapharma
Takeda Pharmaceuticals International
Fonds de dotation CSL Behring pour la recherche
BioCryst
Article History
Received: 3 July 2023
Accepted: 11 September 2023
First Online: 12 September 2023
Competing interests
: The authors declare no competing interests.